CIBC Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-8,020
| Closed | -$928K | – | 1157 |
|
2023
Q3 | $928K | Buy |
8,020
+118
| +1% | +$13.7K | ﹤0.01% | 653 |
|
2023
Q2 | $813K | Buy |
7,902
+5
| +0.1% | +$514 | ﹤0.01% | 675 |
|
2023
Q1 | $862K | Buy |
7,897
+318
| +4% | +$34.7K | ﹤0.01% | 670 |
|
2022
Q4 | $862K | Sell |
7,579
-2,763
| -27% | -$314K | ﹤0.01% | 681 |
|
2022
Q3 | $640K | Sell |
10,342
-436
| -4% | -$27K | ﹤0.01% | 719 |
|
2022
Q2 | $860K | Sell |
10,778
-19,025
| -64% | -$1.52M | ﹤0.01% | 680 |
|
2022
Q1 | $3.14M | Buy |
29,803
+19,376
| +186% | +$2.04M | 0.01% | 452 |
|
2021
Q4 | $1.12M | Buy |
10,427
+1,209
| +13% | +$130K | ﹤0.01% | 669 |
|
2021
Q3 | $1.01M | Sell |
9,218
-29,154
| -76% | -$3.19M | ﹤0.01% | 676 |
|
2021
Q2 | $3.59M | Buy |
38,372
+4,046
| +12% | +$379K | 0.01% | 411 |
|
2021
Q1 | $3.16M | Buy |
34,326
+27,362
| +393% | +$2.52M | 0.01% | 409 |
|
2020
Q4 | $509K | Hold |
6,964
| – | – | ﹤0.01% | 745 |
|
2020
Q3 | $541K | Buy |
6,964
+172
| +3% | +$13.4K | ﹤0.01% | 695 |
|
2020
Q2 | $377K | Hold |
6,792
| – | – | ﹤0.01% | 746 |
|
2020
Q1 | $201K | Hold |
6,792
| – | – | ﹤0.01% | 876 |
|
2019
Q4 | $246K | Buy |
+6,792
| New | +$246K | ﹤0.01% | 962 |
|